MicroRNA-645 promotes cell metastasis and proliferation of renal clear cell carcinoma by targeting GK5

被引:2
作者
Chen, J. [1 ]
Shu, Y. [1 ]
Yu, Q. [2 ]
Shen, W. [3 ]
机构
[1] Tongde Hosp Zhejiang Prov, Dept Urol, Hangzhou, Zhejiang, Peoples R China
[2] Tradit Chinese Med Hosp Huangyan, Dept Nephrol, Taizhou, Zhejiang, Peoples R China
[3] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China
关键词
microRNAs; Metastasis; Proliferation; SOX9; Renal clear cell carcinoma; CANCER STATISTICS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To dissect the functioning mode of miR-645 on renal clear cell carcinoma cell metastasis and growth, and provide therapeutic targets for renal clear cell carcinoma. PATIENTS AND METHODS: Quantitative Real-time PCR (qRT-PCR) assay was employed to detect miR-645 expression level. Wound healing assay and transwell assay were performed to investigate metastasis capacity of renal clear cell carcinoma cells. Cell Counting Kit 8 (CCK8) assay was incorporated to assess cell proliferation capacity. Flow cytometry was used to identify cell apoptosis and cell cycle distribution. Protein levels were assessed by Western blotting assay. The target gene was predicted and verified by bioinformatics analysis and luciferase assay. RESULTS: MiR-645 was upregulated in renal clear cell carcinoma tissues when compared with para-carcinoma tissues (n=32). Downregulated miR-645 could attenuate cell migration and invasion capacities, as well as inhibited cell proliferation capacity, promoted cell apoptosis and cell cycle arrest at G0/G1 phase. GK5 was chosen as the target gene of miR-645 by bioinformatics analysis and luciferase reporter assay. Moreover, silence of GK5 could rescue tumor suppression role of downregulated miR-645 on renal clear cell carcinoma metastasis. CONCLUSIONS: Knockdown of miR-645 exerted tumor-suppressive effects on renal clear cell carcinoma metastasis and growth via targeting GK5 in vitro, which provided an innovative and candidate target for diagnose and treatment of renal clear cell carcinoma.
引用
收藏
页码:4557 / 4565
页数:9
相关论文
共 23 条
  • [1] Axelson H, 2013, SEMIN CANCER BIOL, V23, P56, DOI 10.1016/j.semcancer.2012.06.005
  • [2] Bokemeyer C, 1996, WORLD J UROL, V14, P354
  • [3] REIN Annual Report
    Couchoud, C.
    Lassalle, M.
    Jacquelinet, C.
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2013, 9 : S3 - S6
  • [4] Targeting non-coding RNA for the therapy of renal disease
    Denby, Laura
    Baker, Andrew H.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2016, 27 : 70 - 77
  • [5] ESBRIT P, 1988, BONE MINER, V4, P7
  • [6] microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies
    Gandellini, Paolo
    Doldi, Valentina
    Zaffaroni, Nadia
    [J]. SEMINARS IN CANCER BIOLOGY, 2017, 44 : 132 - 140
  • [7] Targeting MicroRNAs in Cancer Gene Therapy
    Ji, Weidan
    Sun, Bin
    Su, Changqing
    [J]. GENES, 2017, 8 (01):
  • [8] Kontomanolis Emmanuel N, 2015, Microrna, V4, P18
  • [9] MicroRNAs in renal cell carcinoma: A systematic review of clinical implications (Review)
    Li, Ming
    Wang, Ying
    Song, Yongsheng
    Bu, Renge
    Yin, Bo
    Fei, Xiang
    Guo, Qizhen
    Wu, Bin
    [J]. ONCOLOGY REPORTS, 2015, 33 (04) : 1571 - 1578
  • [10] Li XY, 2015, EUR REV MED PHARMACO, V19, P2112